First Protac Drug Approved, Targets Untreatable Diseases

A revolutionary new class of medicine received approval in 2026, offering hope for conditions that traditional drugs couldn't touch.

Unlike conventional treatments that merely block disease proteins, protac drugs completely destroy them.